Imagine a future where Parkinson’s disease no longer robs individuals of their independence and mobility. That future is closer than you think. Apollo Hospitals, Greams Lane, has taken a giant leap forward with the launch of its groundbreaking Centre of Excellence for Parkinson’s Disease and Deep Brain Stimulation (DBS). This isn’t just another medical facility—it’s a beacon of hope for those battling movement disorders, offering a unique blend of cutting-edge neurosurgery and personalized care. But here’s where it gets even more exciting: the center specializes in next-generation brain-sensing DBS technology, a game-changer that tailors treatment to each patient’s unique needs. This innovation doesn’t just manage symptoms—it transforms lives by significantly improving mobility, independence, and overall quality of life.
Led by esteemed experts Vijayashankar Paramanandam, Senior Consultant Neurologist, and Arvind Sukumaran, Senior Consultant Functional Neurosurgeon, the center is poised to set new standards in Parkinson’s care. During the launch, Ilankumaran Kaliamoorthy, CEO of Apollo Hospitals Chennai Region, emphasized the institution’s commitment to pushing the boundaries of medical science.
But here’s the controversial part: While DBS technology has been hailed as a breakthrough, it’s not without its critics. Some argue that its long-term effects are still not fully understood, and others question its accessibility for patients across socioeconomic lines. Is this the miracle treatment we’ve been waiting for, or does it come with hidden risks? We’d love to hear your thoughts in the comments.
Published – November 20, 2025 11:51 pm IST